SmithTJ, CoynePJ, StaatsPS, DeerT, StearnsLJ, RauckRL, Boortz-MarxRL, BuchserE, CatalàE, BryceDA, CousinsM, PoolGE. An implantable drug delivery system for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive management. Ann Oncol, 2005; 16:825–333.
2.
FlückigerB, KnechtH, GrossmannS, FelleiterP. Device-related complications of long-term intrathecal drug therapy via implanted pumps. Spinal Cord, 2008; 46:639–643.
